Annovis Bio, Inc. (ANVS)
1.92
+0.02
(+1.05%)
USD |
NYSE |
May 29, 16:00
1.97
+0.05
(+2.60%)
After-Hours: 20:00
Annovis Bio EPS Diluted (Quarterly) : -0.6322 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | -0.0873 |
| Gain Therapeutics, Inc. | -0.1328 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Anika Therapeutics, Inc. | -0.3737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.61M |
| Total Expenses (Quarterly) | 17.61M |
| Enterprise Value | 67.46M |
| Earnings Yield | -89.41% |
| Normalized Earnings Yield | -89.10 |